The SARS-CoV-2 virus that causes COVID-19 has killed 6 million people worldwide since 2019.
Mar 21, 2022
0
109
New research reveals factors that control the interplay of natural killer (NK) cells—which are part of the body's innate, or first line, immune response—with tumor cells, viral infections, and solid organ transplants. ...
Mar 16, 2022
0
121
T cells play important roles in helping to fight infections and cancers—and they can also drive autoimmune diseases. Now researchers at La Jolla Institute for Immunology (LJI) have discovered new genes in CD4+ "helper" ...
Feb 25, 2022
0
422
Tufts researchers are building a reputation for precision targeting in drug delivery. Their tools: tiny lipid-based nanoparticles (LNPs) fine-tuned to latch on to specific tissues, organs, even cell types within the body. ...
Feb 23, 2022
0
317
University of Otago researchers have discovered a new function for the hormone prolactin—it limits a new mom's investment in aggressive behavior and instead focuses them on interacting with their babies.
Feb 21, 2022
0
164
Cancerous tumors are made up of rapidly growing, abnormally shaped, cells that can infiltrate and destroy healthy tissues, travel to other parts of the body, and form additional tumors. In part because of its rapid and invasive ...
Feb 7, 2022
0
36
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...
Feb 3, 2022
0
137
Biomedical engineers at Duke University have developed a method to study how key cells in the kidneys become injured and deformed. The new model has revealed a significant mechanism behind severe kidney disease and pointed ...
Jan 26, 2022
0
44
Researchers from The Australian National University (ANU) have identified why certain cells in the body, known as Th17 cells, go rogue and promote the onset of autoimmune diseases such as multiple sclerosis (MS).
Jan 26, 2022
0
188
Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new designer biosensors that 'switch on' color or electrical responses to drugs used in cancer, arthritis, and organ transplant ...
Dec 19, 2021
1
44
